The depressive disorders market presents opportunities through innovation in therapies and drug development with novel ...

Analysts have high hopes for the depression drug, which would be the first in it class if it were to be approved.

Transcranial magnetic stimulation and ketamine have been effective in treating depression. But when patients still struggle ...

Neurocrine Biosciences, Inc. ( NASDAQ: NBIX) TD Cowen's 5th Annual Novel Mechanisms in Neuropsychiatry & Epilepsy Summit September 17, 2025 12:40 PM EDT ...

Eye movement desensitization and reprocessing (EMDR), an empirically validated tool for treating PTSD, is now being used for performance enhancement in sports and other domains.

OCD and BFRBs can look alike, but they’re not the same. Discover the similarities, important distinctions, and what they mean for treatment and recovery.

Otsuka receive CRL from US FDA for sNDA of Rexulti in combination with sertraline to treat adults with post-traumatic stress disorder: Japan Monday, September 22, 2025, 10:00 Hrs ...

Positive Phase 1 study showed safety, tolerability and a linear pharmacokinetic: pharmacodynamic: efficacy relationship (1: 1: 1)Planning ...

Prurigo Nodularis market to exhibit growth at a CAGR of 23.2% (2020-2034), driven by strong uptake of DUPIXENT, recent approval of NEMLUVIO, promising JAK and OX40 inhibitors in the Pipeline, along ...

A new study published in Nature Medicine provides more evidence that ketamine’s rapid antidepressant effects may be partially ...

New research published in Nature Neuroscience provides evidence that a non-hallucinogenic analog of psychedelic drugs can ...

Detailed price information for Enveric Biosciences Inc (ENVB-Q) from The Globe and Mail including charting and trades.